'Migraine Experience' Debuts Excedrin Advertising By Glaxo/Novartis JV
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
Excedrin Migraine’s multi-channel campaign, the first major promotion for the brand since moving into the Glaxo/Novartis JV, incorporates "augmented reality" technology for a window into the struggles of migraine sufferers.
You may also be interested in...
Relief For Excedrin Migraine, Green For Package
Approved changes are for primary display panel on immediate container and outer carton for total of eight packages, from 24- to 300-count, and include making the brand name Excedrin Migraine Relief.
Novartis OTC Plant Troubled By Quality Failures A Year After Shutdown
FDA recorded nine observations – many of them repeats from 2011 and 2012 – on a form 483 during its early 2013 visit to Novartis Consumer Health’s facility in Lincoln, Nebraska. The observations cited inadequate consumer complaint handling and container closure stability testing.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”